The Value of Microsampling (MPI Research)
The volume of blood samples required for bioanalysis has been reduced over the last decade, primarily due to increased sensitivity in analytical techniques. However, there is still room for improvement in this area.
MPI Research understands how effective microsampling – the use of smaller volumes of blood for analytical purposes – can create cost and timeline efficiencies as pharmaceutical and biotechnology companies move their drug development candidates along the pathway to approval. We understand that employing successful microsampling techniques can be challenging. MPI Research is highly experienced in assisting Sponsors achieve timely benefits, given its scientific precision and expertise with microsampling.